Neoplasm Metastasis: all 3,564 studies
Page 18 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial CarcinomaActive, not recruitingNCT05335941Phase 2
- Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET TrialActive, not recruitingNCT05327010Phase 2
- Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.Status unknownNCT05326425Phase 2
- Comparison Between LDCT With DL Recontruction and Standard Dose CTActive, not recruitingNCT05324046
- Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable MetastasesStatus unknownNCT05322486
- Ubuntu - I Am Because We AreCompletedNCT05314179Not applicable
- Early Recovery After "Wedge Resection" Surgery to Remove Lung Mestastasis Secondary to Bone Cancer.CompletedNCT05310539
- Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal MetastasisStatus unknownNCT05305885Not applicable
- Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood FlowCompletedNCT05305378
- A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid TumorsStatus unknownNCT05302843Phase 1
- KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT05294172Phase 3
- Argipressin's Influence on Blood Loss During Hepatic ResectionCompletedNCT05293041Phase 4
- Evaluation of Fast, Same-day Delivery of Palliative Radiotherapy Without a Planning CT (FAST-METS)Status unknownNCT05288608
- Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)CompletedNCT05282901Phase 2
- First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsActive, not recruitingNCT05277051Phase 1
- Thiopurine Enhanced Mutations for PD-1/Ligand-1 EfficacyCompletedNCT05276284Phase 1/2
- A Study to Investigate LYL797 in Adults With Solid TumorsTerminatedNCT05274451Phase 1
- Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.CompletedNCT05273489
- A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT05271604Phase 2
- Independent Risk Factors Analysis and Model Construction For Recurrence After Radiofrequency/Microwave Ablation of Colorectal Cancer With Liver Metastases: a Retrospective, Multicenter TrialStatus unknownNCT05268549
- Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib TreatmentActive, not recruitingNCT05261399Phase 3
- CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver MetastasesCompletedNCT05261113
- A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With CemiplimabActive, not recruitingNCT05259709Phase 1
- Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)WithdrawnNCT05255666Phase 2
- MR Guided Focused Ultrasound vs Radiotherapy for Palliative Pain Tx in Bone MetastasesWithdrawnNCT05250687Not applicable
- Preoperative Imaging in Patients With Small Bowel Neuroendocrine TumorsCompletedNCT05246319
- Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown PrimaryStatus unknownNCT05241132Phase 2
- Treat Primary and Metastatic Liver TumorsWithdrawnNCT05240040
- SSC-COVID in Patients After COVID-19CompletedNCT05233553
- PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsTerminatedNCT05233436Phase 1
- Advanced Planning for Online Accounts and DataWithdrawnNCT05222308Not applicable
- A Trial of SHR6508 in Secondary HyperparathyroidismCompletedNCT05221008Phase 1
- Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial CancerCompletedNCT05219435Phase 2
- Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric CancerStatus unknownNCT05208372
- Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain MetastasesStatus unknownNCT05207904Phase 2
- Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal MetastasisStatus unknownNCT05204173Phase 2
- Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First LineActive, not recruitingNCT05201547Phase 3
- A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114Status unknownNCT05200273Phase 1
- A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary CarcinomaCompletedNCT05191927
- Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA TrialStatus unknownNCT05188911
- Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell CarcinomaCompletedNCT05188118Early Phase 1
- BRIANSTORM - Early Identification of Patients With Brain MetastasesStatus unknownNCT05185557
- Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver MetastasisStatus unknownNCT05183425
- Hippocampal-Sparing Stereotactic Radiosurgery Treatment of Brain Metastases Using CyberKnifeStatus unknownNCT05177185Phase 2
- Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19CompletedNCT05175833Phase 2
- Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal TumorStatus unknownNCT05173467Not applicable
- Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal CancerCompletedNCT05172635
- Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)CompletedNCT05169957Phase 1
- Pain Relief in Symptomatic Bone Metastases With Adjuvant Hyperthermia MR Guided HIFUCompletedNCT05167669Not applicable
- Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)CompletedNCT05165433Phase 1
- Impact de la Marge de résection Sur la Survie à Long Terme et le Taux de récidive Des Patients Atteints de Cancers Colorectaux opérés au CHUS Entre 2006 et 2016 Pour Des métastases hépatiquesCompletedNCT05164419
- Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C MutationApproved for marketingNCT05162443
- Validation of a Multitask Deep Learning System at Spine Metastasis CTCompletedNCT05156567
- Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic MalignancyStatus unknownNCT05154474
- Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR MutationCompletedNCT05146219Phase 2
- A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
- Alpelisib And Sacituzumab Govitecan For Treatment Of Breast CancerActive, not recruitingNCT05143229Phase 1
- LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal ResectionStatus unknownNCT05138094Not applicable
- The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
- Re-TREAT: Re-irradiation for Relapsed Brain MetastasesStatus unknownNCT05126875Not applicable
- A Study of Amivantamab in People With Esophagogastric CancerActive, not recruitingNCT05117931Phase 2
- Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid TumoursCompletedNCT05114668Phase 1
- Holmium-166 Retrospective Collection of Real-World DataCompletedNCT05111795
- Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer CellsStatus unknownNCT05108077Phase 1/2
- The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste DysfunctionsStatus unknownNCT05104424Phase 1
- Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal MetastasesStatus unknownNCT05103020Phase 2
- Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic DiseaseActive, not recruitingNCT05101824Not applicable
- Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of OsteosarcomaCompletedNCT05101655
- A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage AdenocarcinomaSuspendedNCT05101356Phase 1/2
- Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing CancersTerminatedNCT05099549Phase 1/2
- Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Cone Beam Computed Tomography-Guided On-Table Adaptive Planning in a Novel Ring Gantry Radiotherapy DeviceCompletedNCT05096286Not applicable
- Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis DiagnosisCompletedNCT05095766
- Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric CancerStatus unknownNCT05095636Phase 2
- Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care UnitSuspendedNCT05091632
- IORT After Surgical Resection of Brain MetastasesStatus unknownNCT05084092Phase 2
- A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid TumorsCompletedNCT05082610Phase 1
- A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesActive, not recruitingNCT05081609Phase 1/2
- Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic CancerTerminatedNCT05065736Early Phase 1
- Genomic Evolution of Metastasis in Gastric CancerStatus unknownNCT05061082
- Stereotactic Body Radiotherapy Followed by Surgical Stabilization in Spinal MetastasesWithdrawnNCT05060653Not applicable
- Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian CancerStatus unknownNCT05059782Not applicable
- Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)Status unknownNCT05056389Phase 1
- RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid TumorsTerminatedNCT05052255Phase 1/2
- Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial TumoursCompletedNCT05043714Phase 1
- Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCCActive, not recruitingNCT05043090Phase 3
- A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the BoneCompletedNCT05038124Not applicable
- Prognostic Factors and Oncological Outcomes in Laparoscopic Liver Resection for CRLMCompletedNCT05036265
- Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesActive, not recruitingNCT05034497Phase 1
- Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid CancerCompletedNCT05032092Not applicable
- Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MSWithdrawnNCT05029609Phase 1
- A Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid TumorsCompletedNCT05028556Phase 1
- Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLCCompletedNCT05021328Phase 1
- Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical CancerCompletedNCT05021237Phase 2
- ARX788 in HER2-positive Breast Cancer Patients With Brain MetastasesStatus unknownNCT05018702Phase 2
- Hydroxychloroquine and Indapamide in SPMSStatus unknownNCT05013463Phase 2
- Survival Impact of Internal Mammary or Supraclavicular LymphadenectomyCompletedNCT05005650
- Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node MetastasisStatus unknownNCT05002686Phase 2/3
- A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCActive, not recruitingNCT04995523Phase 1/2
- A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary HyperparathyroidismStatus unknownNCT04994080Phase 3
- Niraparib in Tumors Metastatic to the CNSActive, not recruitingNCT04992013Phase 2